146 related articles for article (PubMed ID: 11061619)
1. Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma.
Anthoney DA; Bone I; Evans TR
Ann Oncol; 2000 Sep; 11(9):1197-200. PubMed ID: 11061619
[TBL] [Abstract][Full Text] [Related]
2. Chronic inflammatory demyelinating polyneuropathy associated with metastatic malignant melanoma of unknown primary origin.
Palma JA; Martín-Algarra S
J Neurooncol; 2009 Sep; 94(2):279-81. PubMed ID: 19266164
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients.
Patel AS; Snook RJ; Sehdev A
Discov Med; 2019 Aug; 28(152):107-111. PubMed ID: 31926582
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha.
Meriggioli MN; Rowin J
Muscle Nerve; 2000 Mar; 23(3):433-5. PubMed ID: 10679722
[TBL] [Abstract][Full Text] [Related]
5. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
[TBL] [Abstract][Full Text] [Related]
6. [Chronic inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alpha 2b in a patient with HIV/HCV coinfection: case report].
Bassetti BR; Trés ES; Ciríaco JG; Pinto Neto LF
Rev Soc Bras Med Trop; 2010; 43(1):89-91. PubMed ID: 20305976
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory demyelinating polyneuropathy and malignancy: A systematic review.
Rajabally YA; Attarian S
Muscle Nerve; 2018 Jun; 57(6):875-883. PubMed ID: 29194677
[TBL] [Abstract][Full Text] [Related]
8. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab.
Cafuir L; Lawson D; Desai N; Kesner V; Voloschin A
J Immunother Cancer; 2018 Jan; 6(1):11. PubMed ID: 29382383
[TBL] [Abstract][Full Text] [Related]
10. Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma.
Nishihori T; Abdo-Matkiwsky M; Fleishman SB; Blum RH
Am J Clin Oncol; 2005 Oct; 28(5):526. PubMed ID: 16199995
[TBL] [Abstract][Full Text] [Related]
11. Focal neurological signs and symptoms induced by interferon-alpha in two patients with malignant melanoma.
Herbst RA; Gutzmer R; Jung EG; Kapp A; Weiss J
Br J Dermatol; 1997 Dec; 137(6):1022-3. PubMed ID: 9470935
[No Abstract] [Full Text] [Related]
12. Chronic inflammatory demyelinating polyneuropathy following treatment with peglated interferon α-2a for chronic hepatitis C virus infection.
Ying C; Xue-Mei H; Yao G; Song-Yan L
Neurol India; 2011; 59(1):141-2. PubMed ID: 21339691
[No Abstract] [Full Text] [Related]
13. Hypertriglyceridaemia following adjuvant interferon-alpha treatment in two patients with malignant melanoma.
Junghans V; Rünger TM
Br J Dermatol; 1999 Jan; 140(1):183-4. PubMed ID: 10215802
[No Abstract] [Full Text] [Related]
14. Immunotherapy-induced leukoderma from treatment of melanoma with IL-2: a case report and a review of the literature.
Gathings R; Lewallen R; Yosipovitch G
Acta Derm Venereol; 2015 Feb; 95(2):197-200. PubMed ID: 24820241
[TBL] [Abstract][Full Text] [Related]
15. [High-dose interferon alpha in treatment of patients with malignant melanoma, monitoring of predictive and prognostic biomarkers].
Vanásková J; Grim J; Kopecký J; Kubala E; Filip S
Klin Onkol; 2011; 24(3):180-6. PubMed ID: 21717787
[TBL] [Abstract][Full Text] [Related]
16. Lichen planus induced by interferon-alpha-2B therapy in a patient with cutaneous malignant melanoma.
Herrera Saval A; Camacho Martínez F
Acta Derm Venereol; 1999 Sep; 79(5):395. PubMed ID: 10494726
[No Abstract] [Full Text] [Related]
17. [Interferons and malignant melanoma].
Dreno B
Rev Med Interne; 2002 Nov; 23 Suppl 4():489s-493s. PubMed ID: 12481404
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?
Radny P; Bauer J; Caroli UM; Eigentler TK; Kamin A; Metzler G; Garbe C
Dermatology; 2004; 209(3):249-50. PubMed ID: 15459547
[No Abstract] [Full Text] [Related]
19. Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.
de Maleissye MF; Nicolas G; Saiag P
N Engl J Med; 2016 Jul; 375(3):296-7. PubMed ID: 27468083
[No Abstract] [Full Text] [Related]
20. Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma.
Bird SJ; Brown MJ; Shy ME; Scherer SS
Neurology; 1996 Mar; 46(3):822-4. PubMed ID: 8618691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
